| First Author | Chen R | Year | 2022 |
| Journal | Redox Biol | Volume | 58 |
| Pages | 102513 | PubMed ID | 36334381 |
| Mgi Jnum | J:341718 | Mgi Id | MGI:7383985 |
| Doi | 10.1016/j.redox.2022.102513 | Citation | Chen R, et al. (2022) Macrophage Sprouty4 deficiency diminishes sepsis-induced acute lung injury in mice. Redox Biol 58:102513 |
| abstractText | OBJECTIVE: Inflammation and oxidative stress play critical roles in sepsis-induced acute lung injury (ALI). Sprout4 (Spry4) is involved in regulating inflammation and tissue injury; however, its role and mechanism in sepsis-induced ALI remain elusive. METHODS: Macrophage-specific Spry4 knockout (Spry4(MKO)), transgenic (Spry4(MTG)) mice and matched control littermates were generated and exposed to cecum ligation and puncture (CLP) surgery to establish bacterial sepsis-induced ALI. Bone marrow-derived macrophages (BMDMs) from Spry4(MKO) or Spry4(MTG) mice were isolated and subjected to lipopolysaccharide (LPS) stimulation to further validate the role of Spry4 in vitro. To verify the necessity of AMP-activated protein kinase (AMPK), Spry4 and AMPK double knockout mice and compound C were used in vivo and in vitro. BMDMs were treated with STO-609 to inhibit calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2). RESULTS: We found that macrophage Spry4 was increased in CLP mice and positively correlated with sepsis-induced ALI. Macrophage Spry4 deficiency prevented, while macrophage Spry4 overexpression exacerbated sepsis-induced inflammation, oxidative stress and ALI in mice and BMDMs. Mechanistic studies revealed that macrophage Spry4 deficiency alleviated sepsis-induced ALI through activating CaMKK2/AMPK pathway. CONCLUSION: Our study identify macrophage Spry4 as a promising predictive and therapeutic target of sepsis-induced ALI. |
